Volume 23 - Issue 10 - October 2010
While this author concedes there is no universal definition of hypermobility and a lack of evidence-based medicine to support hypermobility as a cause or effect of hallux valgus, he cites some research and clinical experience that suggest hypermobility as a possible factor in bunion formation.
By Gary M. Rothenberg, DPM, FACFAS
Does hypermobility cause bunions or did the bunion result in hypermobility? The question is admittedly difficult to answer, mostly because we cannot universally agree on a definition of hypermobility.
In recent years, there has been a growing interest in the neurophysiological effects that orthoses can have on the foot. Accordingly, these authors review the literature and offer their perspectives on the ability of orthoses and insoles to enhance postural stability.
Orthotics Q&A »
Which paradigms, teachings and studies influence podiatric physicians who prescribe orthotics? These expert panelists enumerate what factors come into play when they dispense orthoses.
Which of the more current paradigms for foot function have the most influence in your practice?
“Time devoted to evaluating a patient in regard to his or her function as well as the biomechanical problem prior to prescribing the orthotic device will result in greater success with the completed orthotic device,” advises Ronald Valmassy, DPM.
Dermatology Diagnosis »
A 44-year-old competitive runner presented with a history of painful lesions on the plantar aspect of both feet. He stated that the problem initially began with the presence of a single lesion. He denied any history of trauma to the area and indicated that there has never been any bleeding from the site. Further lesions developed and they started to cause some discomfort while he was running.
Diabetes Watch »
Recent data suggests that three visits to a podiatrist prior to development of an ulceration correlates with better overall outcomes with fewer hospitalizations and decreased associated healthcare costs for patients with diabetes.1 As the incidence of diabetes continues to rise among the general population, this study reinforces the value of the podiatric physician within the community and the overall realm of public health.
News and Trends »
Can Advanced Therapies Speed Healing Of DFUs?
By Brian McCurdy, Senior Editor
Given that diabetic foot ulcers can result in complications as devastating as amputation, timely healing of such ulcers is critical. A new study in the Archives of Dermatology cites the benefits of advanced biological therapies.
The study focused on 2,517 patients with diabetic neuropathic foot ulcers who received advanced biological therapy via Apligraf (Organogenesis), becaplermin (Regranex, Systagenix Wound Management) or Procuren (Cytomedix).